Dr. Gail Wyatt is a Clinical Psychologist, Sex Therapist and Professor at UCLA, was the first person of color to receive an NIMH Research Scientist Career Development Awardee for 17 years. Her research examines the consensual and abusive sexual relationships of women and men, the effects of these experiences on their psychological well-being and the cultural context of risks for STIs and HIV. She has conducted national and international research funded by the NIMH, NIDA, State and private funders since 1980. The recipient of numerous awards, Dr. Wyatt has over 250 publications in journals and book chapters, and has co-edited or written 6 books. Dr. Wyatt is the Associate Director of the UCLA AIDS Institute and the Director of the NIMH funded, UCLA Center for Culture, Trauma and Mental Health Disparities. She also directs the Phodiso Project that trains South African investigators to conduct research in culture, trauma and mental health. She coordinates a core of behavioral scientists that consult with other researchers to recruit underserved populations, conduct research that effectively incorporates socio-cultural factors in HIV/AIDS research, and identifies the etiology of health disparities. She also directs the HIV/AIDS Translational Training Program to increase the expertise of underrepresented minorities who will receive funding from NIMH. Finally, she directs the Sexual Health Program at UCLA to offer sexuality education training and research to the campus, local and national communities.
Norweeta G. Milburn, Ph.D. is a Professor-in-Residence in the Department of Psychiatry and Biobehavioral Sciences at the UCLA Semel Institute Center for Community Health. She received her Ph.D. in Community Psychology from the University of Michigan (Ann Arbor). Prior to coming to UCLA, she was an Associate Professor of Psychology at Hofstra University in New York and Assistant Director of the Psy.D. Program in School/Community Psychology. Her research interests include homelessness, substance abuse, family interventions and mental health.
She has been a principal investigator of National Institute on Drug Abuse (NIDA) research on homeless adults and a co-principal investigator of U.S. Department of Education research on coping and adaptation in older African Americans, and was a co-principal investigator of a National Institute of Mental Health investigation of anxiety and depression in older African Americans. As a principal investigator of National Institute of Mental Health and NIDA studies of homeless and African American youth, she has examined paths into and out of homelessness, and risk for HIV among homeless youth in the U.S. and Australia; is implementing a behavioral intervention for homeless adolescents at risk for HIV and their families; and testing recruitment strategies for behavioral interventions.
Alison Hamilton, Ph.D., M.P.H., is an Associate Research Anthropologist in the Department of Psychiatry at UCLA and a Research Health Scientist at the VA Greater Los Angeles Healthcare System. She received her Ph.D. in anthropology from UCLA in 2002, and her M.P.H. in Community Health Sciences from UCLA in 2009. Dr. Hamilton currently has an NIH Career Development Award (NIDA K01 DA017647) to study women methamphetamine users and sexuality. This study focuses intensively on women’s life histories of trauma and their relationship to substance abuse, adult trauma and violence, and sexual experiences. Dr. Hamilton also serves as a Co-Investigator on VA-funded studies of (1) determinants of genetics and genomics services in the VA; (2) quality improvement in care for veterans with severe mental illness (SMI); and (3) utilization of peer support technicians in intensive case management teams for veterans with SMI. She is Principal Investigator on a SAMHSA-funded evaluation of a modified therapeutic community for dually diagnosed male veterans, and she is co-PI on a privately funded pilot study of high-functioning individuals with schizophrenia. Utilizing qualitative and mixed methodologies, her areas of specialty are substance abuse, sexuality, HIV risk, trauma, mental health, women’s health, evaluation research, and health services quality improvement.
Ian W. Holloway, PhD, LCSW, MPH is a licensed clinical social worker and an associate professor of social welfare in the UCLA Luskin School of Public Affaris. Professor Holloway’s applied behavioral health research examines the contextual factors that contribute to heath disparities among sexual and gender minority populations. He is an expert in social network analysis and is particularly interested in how social media and new technologies can be harnessed for health promotion and disease prevention. Dr. Holloway has been a principal investigator on research studies funded by the National Institute on Drug Abuse (NIDA), the Department of Defense, and the California HIV/AIDS Research Program (CHRP). He currently directs the Southern California HIV/AIDS Policy Research Center, which brings the most relevant and timely evidence to bear on California’s efforts to develop and maintain efficient, cost-effective, and accessible programs and services to people living with or at risk for HIV/AIDS.
Larissa Mooney, M.D., Co-Investigator/Faculty Mentor, is an Associate Clinical Professor in the UCLA Department of Psychiatry and Biobehavioral Sciences with expertise in the treatment of substance use disorders and psychiatric comorbidity. She has served as a Co-Investigator and study physician on multiple behavioral and pharmacological intervention trials for substance use disorders at UCLA Integrated Substance Abuse Programs. She was previously the Co-Lead Investigator for the Pacific Region Node of the NIDA Clinical Trials Network (PI, Ling) and the UCLA site PI for multiple medication intervention trials for substance use disorders. She is currently a PI on NIDA-funded investigations of functional outcomes associated with cannabis use reduction and a patient decision aid for opioid use disorder medication treatment. Dr. Mooney provides our HA-STTP team with clinical expertise related to psychiatric comorbidities, health conditions, and public health outcomes associated with substance use disorders.